Search

everythinglearnresearchcommunity

for

Search:↓

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

CGF therapy may help hair regrowth and improve scars in DLE patients.

Red ink tattoos can cause severe skin reactions and complications, especially in those with autoimmune tendencies.

Some children may develop hair loss after having COVID-19.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Gut bacteria may influence hair loss in alopecia areata.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Minoxidil may help treat hair loss by reducing inflammation-related gene activity in skin cells.

Hemp's compounds can be used in natural insecticides, cosmetics, and food supplements.

Selenium from plants is beneficial and safer for health.

Induced pluripotent stem cells are a major breakthrough in regenerative medicine.

Exosomes show promise in improving skin health and appearance.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

Adipose tissue therapies have advanced from tissue to cell and cell-free treatments, showing promise but also limitations.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Combining platelet-rich plasma therapy with prostaglandin-F eye drops can significantly regrow hair in alopecia universalis.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Smoking harms skin quality and health, which may encourage quitting.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.